HemoCue Logo
X

Select your destination

This is Hemocue's global website and may contain information on products not released in all markets.
For information on products and services in your local market, please proceed to your local Hemocue website.

Continue to Hemocue.com

Diabetes, HIV and NCDs

NCDs and HIV - How to simultaneously address needs and enhance care?

Major advances have been made in combating infectious diseases, like HIV, tuberculosis, hepatitis or malaria. Efforts to fight HIV/AIDS have paid off, and treatment is more accessible. However, in low- and middle-income countries, the fast rise of noncommunicable diseases (NCDs) pose new types of challenges - not only for chronic HIV care, but also in terms of achieving the Sustainable Development Goals (SDGs) set by member countries of United Nations. 

HemoCue contribute to provide accurate point-of-care testing (POCT) systems for glucose management. A system from HemoCue is sensitive enough for diagnosing, screening and monitoring of diabetes Type 1, Type 2 and gestational diabetes. 

Explore how the HemoCue diabetes POC testing portfolio can assist you, optimize your workflow and deliver lab accurate results at the point of care within minutes. 

Cookies are used on this site

Use of cookies